INS and type 1 diabetes mellitus: A variety of abnormal autoantibodies can be produced in patients, such as anti-glutamic acid decarboxylase antibodies, insulin antibodies, islet cell antibodies, etc. The most common treatment for T1D is the injection of artificial insulin preparations, but this does not provide a cure.